Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Does saxenda have a generic?Until when novartis has protected market for piqray in the us?Can you provide more details about apotex's ruxolitinib anda filing?Dr reddy's fluoxetine prozac exclusivity 2001 revenue?Isentress buy online?
See the DrugPatentWatch profile for sapropterin
Sapropterin therapy primarily benefits people with neopterin synthase (PTPS) deficiency, the inherited metabolic condition sometimes described as hyperphenylalaninemia due to tetrahydrobiopterin (BH4) deficiency. In this disorder, sapropterin (synthetic BH4) can lower phenylalanine levels and improve dietary and metabolic control [1].
The main target is elevated phenylalanine (commonly in newborn screening or follow-up testing for hyperphenylalaninemia). Sapropterin is used when the hyperphenylalaninemia is expected to be BH4-responsive, meaning the patient’s condition improves with BH4 supplementation [1].
If hyperphenylalaninemia is caused by mechanisms that are not BH4-responsive (for example, classic phenylalanine hydroxylase deficiency without meaningful BH4 responsiveness), sapropterin may not reduce phenylalanine levels enough to be the main treatment. Those cases typically rely more on dietary management and other standard approaches to control phenylalanine [1].
[1] https://www.drugs.com/sapropterin.html
Other Questions About Sapropterin :